CRL vs VNDA · rev $4.02B vs rev $102.2M
Charles River Laboratories (CRL) versus Vanda Pharmaceuticals Inc (VNDA) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. CRL currently screens at market cap $7.78B.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
CRL currently screens at market cap $7.78B. VNDA currently screens at market cap $358.4M.
Not investment advice. Open the CRL and VNDA stock pages for the full models.
Not investment advice.